| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. | Director | Option to purchase Common Stock | 21,216 | $144,268 | $6.80 | 05 Nov 2025 | Direct |
| Ayala Pharmaceuticals, Inc. | Director | Common Stock | 93 | $37 | $0.4000 | 19 Jan 2023 | Direct |
| Ayala Pharmaceuticals, Inc. | Director | Common Stock | 46 | $18 | $0.4000 | 19 Jan 2023 | Held by Reporting Person's Son |
| Orgenesis Inc. | Director | Stock Option | 20,450 | 20 Dec 2023 | Direct | ||
| Ayala Pharmaceuticals, Inc. | Director | Stock Option | 2,342 | 19 Jan 2023 | Direct | ||
| Old Ayala, Inc | Director | Common Stock | 0 | 19 Jan 2023 | Held by Reporting Person's son | ||
| Old Ayala, Inc | Director | Stock Option (right to buy) | 0 | 19 Jan 2023 | Direct |